A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

Partnering with Texas pathology group enables a genetics-focused strategy to address the hidden epidemic of celiac diseaseIRVINE, Calif. and SAN ANTONIO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Targeted ...

A salivary miRNA test for endometriosis shows high accuracy; however, experts debate whether it can replace laparoscopy.

The global diagnostic tools market, covering medical diagnostics and imaging, is experiencing robust growth. Key drivers ...

Researchers at the UNC School of Medicine have developed a tool that can identify airway mucus abnormalities in patients with ...

The eels, including breeding stock thought to be 40 to 50 years old, were found dead in the Waiatāi Stream near Wairoa last ...

Chlamydia pneumoniae—a common bacterium that causes pneumonia and sinus infections—can linger in the eye and brain for years ...

If you are associated with the medical field or want to invest in this sector, opening a pathology lab can prove to be a good ...

New microbiome data show that intestinal bacteria can generate clinically relevant alcohol levels, validating a rare syndrome ...

Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancerLargest real-world, ...

HPV causes about 36,000 cancer cases each year in the U.S.

A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian ...